Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Neurometrix (NURO)
NASDAQ:NURO
Neurometrix (NURO) Stock Price & Analysis
293 Followers
NURO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.93 - $4.73
Previous Close$1.01
Volume1.50M
Average Volume (3M)52.78K
Market Cap
$8.23M
Enterprise Value-$11.69M
Total Cash (Recent Filing)$20.25M
Total Debt (Recent Filing)$328.74K
Price to Earnings (P/E)-1.5
Beta2.78
Next Earnings
Jul 20, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding7,839,549
10 Day Avg. Volume48,242
30 Day Avg. Volume52,777
Standard Deviation0.51
R-Squared0.06
Alpha0.00303
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)4.77
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-2.01
Enterprise Value/Gross Profit-2.03
Enterprise Value/Ebitda-6.77
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Neurometrix News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NURO FAQ
What was Neurometrix’s price range in the past 12 months?
Neurometrix lowest stock price was $0.93 and its highest was $4.73 in the past 12 months.
What is Neurometrix’s market cap?
Currently, no data Available
When is Neurometrix’s upcoming earnings report date?
Neurometrix’s upcoming earnings report date is Jul 20, 2023 which is in 48 days.
How were Neurometrix’s earnings last quarter?
Neurometrix released its earnings results on May 03, 2023. The company reported -$0.205 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.205.
Is Neurometrix overvalued?
According to Wall Street analysts Neurometrix’s price is currently Overvalued.
Does Neurometrix pay dividends?
Neurometrix does not currently pay dividends.
What is Neurometrix’s EPS estimate?
Neurometrix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neurometrix have?
Neurometrix has 7,839,549 shares outstanding.
What happened to Neurometrix’s price movement after its last earnings report?
Neurometrix reported an EPS of -$0.205 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -23.741%.
Which hedge fund is a major shareholder of Neurometrix?
Currently, no hedge funds are holding shares in NURO
---
Neurometrix Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NURO Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $49.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.99%
12-Months-Change
Fundamentals
Return on Equity
-21.76%
Trailing 12-Months
Asset Growth
-10.05%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Neurometrix
NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.
---
Top 5 ETFs holding NURO
iShares Core S&P Total U.S. Stock Market ETF
$10.20
Up to five ETFs with an Outperform Smart Score that hold NURO. The ETFs are listed according to market value of NURO within the ETF
---
---